Patents by Inventor Claudia Ania PENAFUERTE DIAZ

Claudia Ania PENAFUERTE DIAZ has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD OF TREATING OR AMELIORATING A PATHOGENIC INFECTION BY ADMINISTERING AN INTERLEUKIN-2/TGF-BETA RECEPTOR FUSION POLYPEPTIDE
    Publication number: 20230364186
    Abstract: Provided are multi-functional and multi-valent fusion polypeptides comprising an interleukin polypeptide and two or more TGF? ligand-binding polypeptides. The compositions and methods provided herein are useful in the application of treating and/or preventing pathogenic infections.
    Type: Application
    Filed: April 28, 2023
    Publication date: November 16, 2023
    Inventor: Claudia Ania Penafuerte Diaz
  • Method of treating or ameliorating a pathogenic infection by administering an interleukin-2/TGF-? receptor fusion polypeptide
    Patent number: 11672844
    Abstract: Provided are multi-functional and multi-valent fusion polypeptides comprising an interleukin polypeptide and two or more TGF? ligand-binding polypeptides. The compositions and methods provided herein are useful in the application of treating and/or preventing pathogenic infections.
    Type: Grant
    Filed: February 16, 2022
    Date of Patent: June 13, 2023
    Assignee: Cura Therapeutics, Inc.
    Inventor: Claudia Ania Penafuerte Diaz
  • MULTI-FUNCTIONAL AND MULTI-VALENT INTERLEUKIN-TGF-BETA RECEPTOR FUSION POLYPEPTIDES
    Publication number: 20230023954
    Abstract: Provided are multi-functional and multi-valent fusion polypeptides comprising an interleukin polypeptide and two or more TGF? ligand-binding polypeptides. The compositions and methods provided herein are useful in the application of preventing tumorigenesis and treating cancer.
    Type: Application
    Filed: June 30, 2022
    Publication date: January 26, 2023
    Inventor: Claudia Ania PENAFUERTE DIAZ
  • ANTI-PATHOGEN INTERLEUKIN-TGF-BETA RECEPTOR FUSION POLYPEPTIDES
    Publication number: 20220257712
    Abstract: Provided are multi-functional and multi-valent fusion polypeptides comprising an interleukin polypeptide and two or more TGF? ligand-binding polypeptides. The compositions and methods provided herein are useful in the application of treating and/or preventing pathogenic infections.
    Type: Application
    Filed: February 16, 2022
    Publication date: August 18, 2022
    Inventor: Claudia Ania PENAFUERTE DIAZ
  • Multi-functional and multi-valent interleukin-TGF-beta receptor fusion polypeptides
    Patent number: 11407814
    Abstract: Provided are multi-functional and multi-valent fusion polypeptides comprising an interleukin polypeptide and two or more TGF? ligand-binding polypeptides. The compositions and methods provided herein are useful in the application of preventing tumorigenesis and treating cancer.
    Type: Grant
    Filed: January 12, 2022
    Date of Patent: August 9, 2022
    Assignee: CURA THERAPEUTICS, INC.
    Inventor: Claudia Ania Penafuerte Diaz
  • MULTI-FUNCTIONAL AND MULTI-VALENT INTERLEUKIN-TGF-BETA RECEPTOR FUSION POLYPEPTIDES
    Publication number: 20220127332
    Abstract: Provided are multi-functional and multi-valent fusion polypeptides comprising an interleukin polypeptide and two or more TGF? ligand-binding polypeptides. The compositions and methods provided herein are useful in the application of preventing tumorigenesis and treating cancer.
    Type: Application
    Filed: January 12, 2022
    Publication date: April 28, 2022
    Inventor: Claudia Ania PENAFUERTE DIAZ